Heres Why Were Not Too Worried About Pharvaris Cash Burn Situation
| PHVS Stock | USD 19.41 1.11 6.07% |
Slightly above 54% of Pharvaris' private investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Pharvaris BV suggests that some traders are interested. Pharvaris' investing sentiment can be driven by a variety of factors including economic data, Pharvaris' earnings reports, geopolitical events, and overall market trends.
Pharvaris |
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Read at simplywall.st
 |
Pharvaris Fundamental Analysis
We analyze Pharvaris' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharvaris using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharvaris based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Pharvaris is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Pharvaris BV Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pharvaris stock to make a market-neutral strategy. Peer analysis of Pharvaris could also be used in its relative valuation, which is a method of valuing Pharvaris by comparing valuation metrics with similar companies.
Peers
Pharvaris Related Equities
| DSGN | Design Therapeutics | 4.23 | ||||
| ANTX | AN2 Therapeutics | 2.65 | ||||
| IKNA | Ikena Oncology | 1.80 | ||||
| JANX | Janux Therapeutics | 1.15 | ||||
| ANEB | Anebulo Pharmaceuticals | 0.64 | ||||
| MOLN | Molecular Partners | 0.36 | ||||
| HOWL | Werewolf Therapeutics | 0.54 | ||||
| RZLT | Rezolute | 1.39 | ||||
| MLYS | Mineralys Therapeutics, | 1.45 | ||||
| MNOV | MediciNova | 1.74 | ||||
| PMVP | Pmv Pharmaceuticals | 1.88 | ||||
| ELYM | Eliem Therapeutics | 1.90 | ||||
| STOK | Stoke Therapeutics | 2.11 | ||||
| TYRA | Tyra Biosciences | 3.70 | ||||
| PEPG | PepGen | 5.84 | ||||
| GLUE | Monte Rosa | 9.85 |
Additional Tools for Pharvaris Stock Analysis
When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.